Cargando…

Volume–Function Analysis (LiMAx Test) in Patients with HCC and Cirrhosis Undergoing TACE—A Feasibility Study

BACKGROUND: Transarterial chemoembolization (TACE) is an important therapy for hepatocellular carcinoma (HCC) in cirrhosis. In particular in advanced cirrhosis, post-TACE hepatic failure liver (PTHF) failure may develop. Currently, there is no standardization for the periinterventional risk assessme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reichert, Matthias Christian, Massmann, Alexander, Schulz, Antje, Buecker, Arno, Glanemann, Matthias, Lammert, Frank, Malinowski, Maciej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236026/ https://www.ncbi.nlm.nih.gov/pubmed/32816218 http://dx.doi.org/10.1007/s10620-020-06535-5

Ejemplares similares

LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis
por: Leyh, Catherine, et al.
Publicado: (2022)

Noninvasive diagnosis of chemotherapy induced liver injury by LiMAx test – two case reports and a review of the literature
por: Bednarsch, Jan, et al.
Publicado: (2015)

The LiMAx Test as Selection Criteria in Minimally Invasive Liver Surgery
por: Rahimli, Mirhasan, et al.
Publicado: (2022)

Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test
por: Kaffarnik, Magnus F, et al.
Publicado: (2013)

The Liver Maximum Capacity Test (LiMAx) Is Associated with Short-Term Survival in Patients with Early Stage HCC Undergoing Transarterial Treatment
por: Fischer, Janett, et al.
Publicado: (2022)

Enzymatic liver function measured by LiMAx – a reliable diagnostic and prognostic tool in chronic liver disease
por: Buechter, Matthias, et al.
Publicado: (2019)

Dosing of Antimycotic Treatment in Sepsis–Induced Liver Dysfunction by Functional Liver Testing with LiMAx®
por: Kirchner, Carmen, et al.
Publicado: (2019)

Use of the liver maximum function capacity test (LiMAx) for the management of liver resection in cirrhosis – A case of hypopharyngeal cancer liver metastasis
por: Cammann, S., et al.
Publicado: (2017)

Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study
por: Kaffarnik, Magnus F., et al.
Publicado: (2017)

Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report
por: Buechter, Matthias, et al.
Publicado: (2018)

Enzymatic liver function measured by LiMAx is superior to current standard methods in predicting transplant-free survival after TIPS implantation
por: Rashidi-Alavijeh, Jassin, et al.
Publicado: (2021)

Pharmacokinetics of tigecycline in critically ill patients with liver failure defined by maximal liver function capacity test (LiMAx)
por: Alraish, Rawan, et al.
Publicado: (2020)

Early diagnosis of liver failure in septic patients using the maximal liver function capacity test (LiMAx test): comparison with conventional methods
por: Kaffarnik, M, et al.
Publicado: (2013)

The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCC
por: Sun, Tao, et al.
Publicado: (2023)

THE PHOTOTROPIC EXCITATION OF LIMAX
por: Crozier, W. J., et al.
Publicado: (1929)

Porcine model for the study of liver regeneration enhanced by non-invasive (13)C-methacetin breath test (LiMAx test) and permanent portal venous access
por: Wittauer, Eva-Maria, et al.
Publicado: (2019)

Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

Drug-eluting beads TACE is safe and non-inferior to conventional TACE in HCC patients with TIPS
por: Fan, Wenzhe, et al.
Publicado: (2021)

Feasibility of aortic aneurysm sac embolization using a novel shape memory polymer embolic device
por: Massmann, Alexander, et al.
Publicado: (2023)

A proof of concept study on real-time LiMAx CYP1A2 liver function assessment of donor grafts during normothermic machine perfusion
por: Schurink, Ivo J., et al.
Publicado: (2021)

Changing TACTICS in intermediate HCC: TACE plus sorafenib
por: Radu, Pompilia, et al.
Publicado: (2020)

Correction to: Balloon occluded TACE (B-TACE) vs DEM-TACE for HCC: a single center retrospective case control study
por: Lucatelli, Pierleone, et al.
Publicado: (2021)

COCH predicts survival and adjuvant TACE response in patients with HCC
por: Wang, Chen, et al.
Publicado: (2021)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

The effect of lipiodol deposition in HCC after TACE on the necrosis range of PMCT
por: Sun, HongLiang, et al.
Publicado: (2017)

Hybrid Modelling of Transarterial Chemoembolisation Therapies (TACE) for Hepatocellular Carcinoma (HCC)
por: Perfahl, H., et al.
Publicado: (2020)

CXCL1 and CXCL6 Are Potential Predictors for HCC Response to TACE
por: Kinzler, Maximilian N., et al.
Publicado: (2023)

PHOTOTROPIC CIRCUS MOVEMENTS OF LIMAX AS AFFECTED BY TEMPERATURE
por: Crozier, W. J., et al.
Publicado: (1924)

SUPPRESSION OF PHOTOTROPIC CIRCUS MOVEMENTS OF LIMAX BY STRYCHNINE
por: Crozier, W. J., et al.
Publicado: (1924)

TEMPORARY ABOLITION OF PHOTOTROPISM IN LIMAX AFTER FEEDING
por: Crozier, W. J., et al.
Publicado: (1925)

TEMPERATURE CHARACTERISTIC FOR HEART BEAT FREQUENCY IN LIMAX
por: Crozier, W. J., et al.
Publicado: (1925)

Duration of response after DEB-TACE compared to lipiodol-TACE in HCC-naïve patients: a propensity score matching analysis
por: Bargellini, Irene, et al.
Publicado: (2021)

Published trials of TACE for HCC are often not registered and subject to outcome reporting bias
por: Grégory, Jules, et al.
Publicado: (2020)

Acute and Chronic Inflammation of the Biliary System
por: Zimmer, Vincent, et al.
Publicado: (2015)

Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis
por: Yao, Man, et al.
Publicado: (2022)

THE LOCOMOTION OF LIMAX : I. TEMPERATURE COEFFICIENT OF PEDAL ACTIVITY.
por: Crozier, W. J., et al.
Publicado: (1924)

THE LOCOMOTION OF LIMAX : II. VERTICAL ASCENSION WITH ADDED LOADS.
por: Crozier, W. J., et al.
Publicado: (1925)

RFamidergic neurons in the olfactory centers of the terrestrial slug Limax
por: Matsuo, Yuko, et al.
Publicado: (2018)

HCC: RNA-Sequencing in Cirrhosis
por: Wang, Haoyu, et al.
Publicado: (2023)

Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
por: Liu, Lei, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_l1c2jffaf2quq071aotfrrgccb